For Good Science, You Need Engaged Citizens
By Gregory E. Kaebnick, Michael K. Gusmano,
Scientific American
| 07. 22. 2021
They strengthen the institutions that ensure a strong democracy, leading to rational decisions
Photo by Mika Baumeister on Unsplash
The White House has rehired a climate scientist who was forced out by the Trump administration, and is proposing to dramatically increase the budget of the Centers for Disease Control and Prevention. “Science is back” has become a Biden slogan. But listening to scientists is only the first step—and only a partial step, given the deep distrust many Americans have for experts. We must improve how ordinary citizens help shape science policy.
This is one of the findings of a recent report from the Hastings Center that examines the role of citizens in shaping policy in health and science. That role should not be limited to electing candidates and then, a few years later, expressing approval or disapproval of their job performance. Too many issues are in play at once for the voting–governing connection to be meaningful for many of them, and most people do not choose candidates on the basis of a clear understanding of policies, anyway
It is unlikely, for example, that elections will provide guidance about the governance...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...